The complex health crisis in the Democratic Republic of the Congo (DRC) has worsened since the beginning of 2023. In the east of the country, entire villages have been burned to the ground as intercommunal clashes and armed conflict rage, forcing people to leave their homes for their safety and survival. The area has also seen floods and landslides, further increasing the risk of outbreaks of deadly diseases.

One of these diseases is cholera. Cholera is an acute intestinal infection that spreads through food and water contaminated with faeces containing the bacterium Vibrio cholerae. While the disease has been eliminated from many parts of the world, it continues to affect eastern DRC, marred by years of underdevelopment, conflict and extreme climate events.

In October 2023, the government of DRC launched a plan to eliminate the disease by 2030.

A concerning feature of this outbreak is that the country has reported consistently high cases throughout the year. After an initial peak in April, about a thousand cases have been reported each week. Larger and longer lasting outbreaks mean additional challenges for health workers, who are already overstretched, responding to a number of diseases in extremely challenging circumstances.

WHO has been working closely with the health authorities in the country to respond to this outbreak, providing medical supplies and expertise, facilitating transportation of test samples to labs, as well as building treatment centres to bring healthcare closer to the people facing outbreaks. Cholera is an easily treatable disease, but time is of the essence. In severe cases, quick treatment can make the difference between life and death.

Fighting cholera amidst global shortages

The importance of these measures has become even more important as another tool, the oral cholera vaccine, continues to be in short supply globally. One year ago, the International Coordinating Group on Vaccine Provision—the body which manages emergency supplies of vaccines—made an unprecedented decision to move from a two dose to one dose vaccination regimen for cholera. This decision was compelled by an acute global shortage of the vaccine.

This has meant that vaccines supplied to all countries, including DRC, have fallen short of the need. Still, the country carried out a vaccination campaign reaching over 360 000 people with a single dose each, and a further 5 million people will be reached in the near-future.